Clinical Trial Update: Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluated sunitinib concentrations in recurrent glioblastoma patients not taking enzyme-inducing antiepileptic drugs who are undergoing d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Glioblastoma, Brain Tumor | EARLY_Phase 1 | Status: COMPLETED